Goodwill And Intangible Assets

3 Months Ended

Mar. 31, 2012

Goodwill And Intangible Assets [Abstract]

4. Goodwill and Intangible Assets

The changes in the carrying amount of goodwill for the three months ended March 31, 2012 are as follows:


	Fresh Dairy Direct		WhiteWave- Alpro		Morningstar		Total
	(In thousands)
Balance at December 31, 2011	$	86,841	$	762,336	$	306,094	$	1,155,271
Foreign currency translation		—		4,950		—		4,950

Balance at March 31, 2012	$	86,841	$	767,286	$	306,094	$	1,160,221

The gross carrying amount and accumulated amortization of our intangible assets other than goodwill as of March 31, 2012 and December 31, 2011 are as follows:


	March 31, 2012							December 31, 2011
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
	(In thousands)
Intangible assets with indefinite lives:
Trademarks(1)	$	589,375	$	—		$	589,375	$	586,663	$	—		$	586,663
Intangible assets with finite lives:
Customer-related and other		132,655		(55,800	)		76,855		131,751		(53,652	)		78,099
Trademarks		10,564		(5,204	)		5,360		10,564		(4,938	)		5,626

Total	$	732,594	$	(61,004	)	$	671,590	$	728,978	$	(58,590	)	$	670,388

(1)	The increase in the carrying amount of indefinite-lived trademarks between December 31, 2011 and March 31, 2012 is the result of foreign currency translation adjustments.

Amortization expense on intangible assets for the three months ended March 31, 2012 and 2011 was $2.3 million and $2.7 million, respectively. Estimated aggregate intangible asset amortization expense for the next five years is as follows (in millions):


2012	$	9.3
2013		9.2
2014		8.6
2015		8.5
2016		8.4

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details